Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 3 January 2020
Accepted: 23 April 2020
First Online: 8 May 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Ethics Committee of the Israel Defense Forces Medical Corps (Approval No. 1669–2016) and conformed to the tenets of the Declaration of Helsinki. Participants anonymity was preserved. Patient consent was waived as the raw data was deidentified.
: Not applicable.
: A.B. reports receiving personal fees from Nanoretina and grants from Cellcure, Byonics, Novartis, and MicroSert outside the submitted work. The rest of the authors have no conflicts of interest to disclose.
